台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    59.7
  • 漲跌
    ▼0.3
  • 漲幅
    -0.50%
  • 成交量
    38
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-中國信託 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

中國信託 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/160.159.0000.0059.000.1910.11%
2025/01/13158.9000.0059.401911.09%
2025/01/1000.00159.8059.60-191-1.10%
2025/01/092.160.0000.0060.102.1912.25%
2025/01/03061.9000.0060.600900.01%
2024/12/300.161.1000.0060.800.1900.11%
2024/12/240.161.6000.0062.000.1900.11%
2024/12/190.161.1000.0061.000.1900.11%
2024/12/1800.00161.1061.10-191-1.10%
2024/12/11365.3000.0064.003903.32%
2024/12/0600.00165.4065.90-194-1.05%
2024/12/020.164.6000.0064.900.1970.10%
2024/11/28163.5000.0063.701981.01%
2024/11/250.164.1000.0065.400.1990.10%
2024/11/210.162.00063.4063.300.1940.08%
2024/11/201.268.1100.0064.401.2911.26%
2024/11/1900.00169.1069.30-188-1.12%
2024/11/180.173.0000.0070.700.1900.11%
2024/11/153.172.31072.6072.603.11013.01%
2024/11/14271.5000.0069.7021021.94%
2024/11/135.177.55277.6077.403.1973.18%
2024/11/12186.8900.0086.001901.12%
2024/11/040101.0000.0097.5001320.00%
2024/10/250.196.8000.0096.500.11360.04%
2024/10/22196.5000.0096.6011360.73%
2024/10/170.196.9000.0096.800.11370.04%
2024/10/090.197.5000.0097.400.11380.04%
2024/10/04097.6000.0097.0001380.00%
2024/09/200.197.1000.0096.300.11390.04%
2024/09/1300.000.497.1096.80-0.4140-0.29%
2024/09/10197.3000.0096.5011390.71%
2024/09/031100.5000.00100.5011390.72%
2024/08/2100.000.5104.00102.00-0.5135-0.37%
2024/08/1900.0010105.50106.00-10130-7.68%
2024/08/1200.002103.50102.50-299-2.01%
2024/08/09499.1300.00100.504934.29%
2024/08/081108.001104.50105.000950.00%
2024/08/0710108.9500.00108.00109710.22%
2024/08/050100.5000.0098.800890.00%
2024/07/301100.5000.00100.501891.12%
2024/07/233101.001101.00101.502902.22%
2024/07/181101.5000.00101.501901.10%
2024/07/030102.5000.00101.0001310.00%
2024/06/201100.5000.00101.0011420.70%
2024/06/180.1100.5000.00101.000.11450.03%
2024/06/170.1101.0000.00101.000.11460.03%
2024/06/121100.0000.00101.0011550.64%
2024/06/0700.001102.50102.50-1155-0.64%
2024/06/051102.5000.00102.5011580.63%
2024/06/030103.0000.00102.5001590.00%
2024/05/310.3103.0000.00102.500.31590.16%
2024/05/2700.000102.50102.500158-0.03%
2024/05/172105.002105.00105.5001520.00%
2024/05/160.4106.0000.00107.000.41500.27%
2024/05/145101.604101.03102.0011440.69%
2024/05/132107.0000.00107.0021271.60%
2024/05/103118.5000.00118.5031202.50%
2024/05/0600.002118.75119.00-2118-1.69%
2024/05/030119.0000.00118.5001170.00%
2024/04/241117.5000.00118.0011150.86%
2024/04/171117.0000.00117.0011110.89%
2024/04/1600.003113.67114.00-3111-2.70%
2024/04/1000.001126.00127.00-195-1.04%
2024/04/081123.5000.00123.501731.36%
2024/04/031123.5000.00123.501711.40%
2024/03/260124.502123.00123.00-263-3.12%
2024/03/251123.5000.00124.001621.60%
2024/03/191122.5000.00123.001551.81%
2024/03/181122.5000.00124.001511.95%
2024/03/1500.001121.00121.50-147-2.12%
2024/03/142119.5000.00119.002434.62%
2024/03/111.2114.4200.00114.501.2363.32%
2024/03/071114.5000.00114.001342.91%
2024/02/272112.5000.00112.502326.12%
2024/02/1900.000.6113.00113.00-0.631-1.91%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音